SMi Systems Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Upcoming)

  • Latest Deal Amount
  • $12.8M

  • Investors
  • 2

SMi Systems General Information

Description

Developer of single-molecule discovery and diagnostic tools intended for biomedical research and clinical diagnostics. The company's automated high-throughput platform uses super-resolution microscopy and data analysis software for multi-omic (DNA, RNA, and protein) and multiplexed molecular detection and quantification, enabling researchers and drug developers to analyze molecular interactions and assess drug-target binding.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 23 Longmeadow Lode
  • Cambridge CB25 9HA
  • England, United Kingdom
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Diagnostic Equipment
Corporate Office
  • 23 Longmeadow Lode
  • Cambridge CB25 9HA
  • England, United Kingdom

SMi Systems Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SMi Systems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC $12.8M Upcoming Generating Revenue
4. Later Stage VC 12-Nov-2025 Completed Generating Revenue
3. Seed Round 23-Mar-2023 Completed Generating Revenue
2. Grant 01-Dec-2022 $500K Completed Generating Revenue
1. Grant 01-Aug-2021 $2.62M Completed Generating Revenue
To view SMi Systems’s complete valuation and funding history, request access »

SMi Systems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A1 Shares
A1 Shares
A1 Shares 3,638,820 $0.001326 $1.33 $1.33 1x $1.33 38.46%
To view SMi Systems’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

SMi Systems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of single-molecule discovery and diagnostic tools intended for biomedical research and clinical diagnostics. T
Discovery Tools (Healthcare)
Cambridge, United Kingdom
19 As of 2026

Branford, CT
 

Rockville, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SMi Systems Competitors (12)

One of SMi Systems’s 12 competitors is Quantum-Si, a Formerly VC-backed company based in Branford, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Quantum-Si Formerly VC-backed Branford, CT
Meso Scale Diagnostics Corporation Rockville, MD
Olink Proteomics Formerly PE-Backed Uppsala, Sweden
Nomic Venture Capital-Backed Montreal, Canada
Standard BioTools Formerly VC-backed Boston, MA
You’re viewing 5 of 12 competitors. Get the full list »

SMi Systems Patents

SMi Systems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202304502-D0 An optical microscope for wide-field microscopies Inactive 28-Mar-2023
GB-2628556-A An optical microscope for wide-field microscopies Inactive 28-Mar-2023
GB-202302060-D0 Levelling system for single molecule imaging Inactive 14-Feb-2023
US-20260009995-A1 Levelling system for single molecule imaging Pending 14-Feb-2023
WO-2024170894-A1 Levelling system for single molecule imaging Inactive 14-Feb-2023 G02B21/26
To view SMi Systems’s complete patent history, request access »

SMi Systems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SMi Systems Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Norcliffe Capital Venture Capital Minority
Innovate UK Government
To view SMi Systems’s complete investors history, request access »

SMi Systems FAQs

  • When was SMi Systems founded?

    SMi Systems was founded in 2018.

  • Where is SMi Systems headquartered?

    SMi Systems is headquartered in Cambridge, United Kingdom.

  • What is the size of SMi Systems?

    SMi Systems has 19 total employees.

  • What industry is SMi Systems in?

    SMi Systems’s primary industry is Discovery Tools (Healthcare).

  • Is SMi Systems a private or public company?

    SMi Systems is a Private company.

  • What is SMi Systems’s current revenue?

    The current revenue for SMi Systems is .

  • How much funding has SMi Systems raised over time?

    SMi Systems has raised $7.95M.

  • Who are SMi Systems’s investors?

    Norcliffe Capital and Innovate UK have invested in SMi Systems.

  • Who are SMi Systems’s competitors?

    Quantum-Si, Meso Scale Diagnostics, Olink Proteomics, Nomic, and Standard BioTools are some of the 12 competitors of SMi Systems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process